Suchergebnisse - "Kuznik, Andreas"

PubPharm (9)

1

Moving branded statins to lowest copay tier improves patient adherence

enthalten in: Journal of managed care pharmacy : JMCP | 2014

von Chen, S. | Shah, S. | Lee, Y. | +3

2

Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin

enthalten in: Current medical research and opinion | 2013

von Jacobson, T. | Wertz, D. | Kuznik, A. | +1

3

Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin

enthalten in: The American journal of geriatric pharmacotherapy | 2011

von Swindle, J. | Potash, J. | Kulakodlu, M. | +2

4

Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular risk

enthalten in: American journal of therapeutics | 2011

von Simpson, R. | Signorovitch, J. | Ramakrishnan, K. | +3

5

The value of atorvastatin over the product life cycle in the United States

enthalten in: Clinical therapeutics | 2011

von Grabner, M. | Johnson, W. | Abdulhalim, A. | +2

6

Switching from atorvastatin to simvastatin in patients at high cardiovascular risk : effects on low-density lipoprotein cholesterol

enthalten in: American journal of therapeutics | 2010

von Aronow, H. | Hess, G. | Hill, J. | +2

7

Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population

enthalten in: Mayo Clinic proceedings | 2009

von Simpson, R. | Signorovitch, J. | Birnbaum, H. | +4

CommentIn: Mayo Clin Proc. 2009 Dec;84(12):1059-61. - PMID 19955241

8

Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated

enthalten in: Mayo Clinic proceedings | 2008

von Jacobson, T. | Wertz, D. | Hoy, T. | +3

ErratumIn: Mayo Clin Proc. 2009 Feb;84(2):208

9

Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market : economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study

enthalten in: Clinical therapeutics | 2008

von Mullins, C. | Rattinger, G. | Kuznik, A. | +1

1
[1]